Navigation Links
Gene Thought to Help Kill Cancer Cells may Actually Help Them Thrive

A new study of chemo patients, scientists at the Georgia Institute of Technology and the Ovarian Cancer Institute has revealed that a gene , p53, thought to be essential in helping chemotherapy kill cancer cells, may actually help them thrive.

The researchers found that 70 percent of subjects whose tumors had mutations in the gene p53 were still alive after five years. Patients with normal p53 displayed only a 30 percent survival rate.

The findings raise the possibility of a new strategy for fighting cancer - namely, developing drugs to disable the functioning of this gene in the tumors of patients undergoing chemotherapy.

P53 has long been recognized as a key player in directing chemotherapy-damaged cancer cells to self annihilate, but less attention has been paid to p53s role in repairing damaged cells, said John McDonald, chair of Georgia Techs School of Biology and chief research scientist at the Ovarian Cancer Institute.

Georgia Tech researchers found that p53 may be a double-edged sword. Chemotherapy patients whose tumors had a mutated p53 gene that didn't work had a much better survival rate than those who had normal p53.

In the study, researchers took malignant and benign ovarian tumors straight from the operating room and compared their gene expression profiles. Some of the cancer patients had been treated with chemotherapy prior to surgery, and some had not. At this point researchers didn't consider whether the patients actually had malignant tumors or had been treated with chemotherapy.

However, they found that the gene expression profiles of the tumors clustered the chemotherapy-treated patients into two groups: those whose profiles were similar to cancer patients who had not been treated with chemo and those whose profiles were similar to patients with benign tumors.

As they continued their analysis, they found that the main difference between the groups'
'"/>




Page: 1 2

Related medicine news :

1. Genetic Pills A Future Thought
2. Antidepressant Medication Leading To Suicidal Thoughts
3. Soy Benefits May Not Be As Much As Thought Before
4. Mice With Human Thought Processes Could Be Developed In The Future
5. HPV Thought To Be a Culprit in Skin Cancer
6. High Spirits :Second Thoughts on the Mini Pegs
7. Death Pumps Up Aggressive Thoughts
8. Japanese Scientists Develop Thought-Controlled Robotic Hands
9. Scientists Develop Thought-Controlled Robotic Hands
10. Inculcating Positive Thoughts Could Eliminate Depressive Mood
11. Obesity Surgery Complication Rates Higher than Previously Thought
Post Your Comments:
(Date:7/9/2008)... DRE, Inc., a premier international ...ts customers that as much as $250,000 in medical e...e tax filings. , Louisvil...us Act of 2008, in accordance with Tax Code Sectio...equipment bought in 2008. This could make 2008 an ...
(Date:7/9/2008)... While SmartLipo has swept the natio...popular fat removal procedure has leaped forward. ...privileged to be the first in his state to offer t...lard is also one of only two plastic surgeons auth...is procedure. , Lone Tree...
(Date:7/8/2008)...ON, July 8 /PRNewswire-USNewswire/ -- The Justice ...ettlement with the Medical Weight,Loss Clinic, whi...e,Americans with Disabilities Act (ADA). It was al...erve a prospective client because she has HIV,dise...al Weight Loss Clinic will,provide training on the...
(Date:7/8/2008)... SKINTASTIC™ is pleased to a...®--the latest injectable collagen filler in th...uty treatments. EVOLENCE® utilizes highly-puri...red medical grafting substance due to its nearly i... N. Dallas/Plano, TX (PRWEB) July 8...
Breaking Medicine News(10 mins):Health News:Economic Stimulus Act Can Improve Medical Equipment Purchasing Power 2Health News:John A. Millard, M.D. is 1st Surgeon in Colorado to Offer Smartlipo MPX™ 2Health News:John A. Millard, M.D. is 1st Surgeon in Colorado to Offer Smartlipo MPX™ 3Health News:Justice Department Reaches Settlement Agreement With Medical Weight Loss Clinic 2Health News:Move Over, Popular Beauty Fillers--Here Comes Evolence 2Health News:Move Over, Popular Beauty Fillers--Here Comes Evolence 3
...f the ancient Chinese medical practices that has g...ed for children. Paediatricians suggest that along...icine practice should// also be offered to paediat... significant rise in the number of visits made to ...
...n the British Medical Journal has suggested that p... of female sexual disorders and are defining the c... products. Drug companies are trying to recreate//..., the drug used to treat male impotence, created d...
... transfusions among critically ill patients may no...at patients in intensive care with a lowered need ...kly administration //of the man-made protein. Rese...a substance called recombinant human erythropoieti...
...Argentina in a World Cup match in 1998 ending with...by 27 per cent. The fact that extreme stress and e...ople is known to almost everyone.However, research...match between England and Argentina during the 199...
Other Medicine News:
(Date:7/3/2008)...wire-FirstCall/ -- Medivation, Inc.,(Nasdaq: MDVN...nce at 5:00,p.m. EDT on Monday, July 7, to discuss...d, placebo-controlled Phase 2 clinical trial of,di...e/Webcast Details, To participate in the live cal...telephone, please dial 877-419-6590 from the U.S. ...
(Date:7/3/2008)...RIDGE Massachusetts, July 3,/PRNewswire-FirstCall/...ogy company, Jerini AG for an equity purchase pri... (HAE) product, FIRAZYR(R), to its Human Genetic T...lobal sales expected to be around $350-400 millio... environment, - Expected to be accretive for Non ...
(Date:7/1/2008)...cation Newsletter Series for Healthcare ...July 1 /- Clostridium difficile infec...ase with a wide spectrum of,severity, ranging from...th.,Recurrent CDI can occur in up to 20% of patien...tients are at increased risk of additional,recurre...
(Date:7/1/2008)... for ,buying time, in victims of lethal ...- For the first time, researchers hav...mounts of inhaled or,intravenous hydrogen sulfide,...ir sulfurous stench -- significantly improves surv...gist Mark B. Roth, Ph.D., and colleagues in the Ba...
Breaking Medicine Technology:Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntington's Disease 2Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 2Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 3Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 4Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 5Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 6Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 7Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 8Current Concepts in Clostridium difficile Infection: A Focus on Recurrent Disease 2'Hibernation-On-Demand' Drug Hydrogen Sulfide Significantly Improves Survival After Extreme Blood Loss 2'Hibernation-On-Demand' Drug Hydrogen Sulfide Significantly Improves Survival After Extreme Blood Loss 3CME LLC Granted Five Year Full Approval by the American Psychological Association 4469 1CME LLC Granted Five Year Full Approval by the American Psychological Association 4469 2Immunosyn Corporation to Present at FSX 1465 1Immunosyn Corporation to Present at FSX 1465 2Abbott Named to Science Magazines List of Top Employers in the Biotech and Pharmaceutical Industry 1463 1Abbott Named to Science Magazines List of Top Employers in the Biotech and Pharmaceutical Industry 1463 2Abbott Named to Science Magazines List of Top Employers in the Biotech and Pharmaceutical Industry 1463 3ABCs Private Practice Inaccurately Portrays Serious Womens Health Condition 1461 1ABCs Private Practice Inaccurately Portrays Serious Womens Health Condition 1461 2
...mends clinical utilization management,programs, ST...macy benefit,manager Prime Therapeutics (Prime) to...ation of Strattera(R) (atomoxetine) for treating,a...children. The,study found that children who start ...their therapy than children who started on,stimula...
...eclinical data for potential combination,therapies... after,ITMN-191 exposure, BARCELONA, Spain, April ... announced today the presentation of findings from...tease inhibitor,ITMN-191, alone or in combination ...f the European Association for the Study of the,Li...
Other Medicine Technology:Study Shows Children With ADHD Who Start on Strattera are More,Likely to Change Therapies 2Study Shows Children With ADHD Who Start on Strattera are More,Likely to Change Therapies 3InterMune Presents Research on ITMN-191 in Hepatitis C at EASL,Annual Meeting 2InterMune Presents Research on ITMN-191 in Hepatitis C at EASL,Annual Meeting 3InterMune Presents Research on ITMN-191 in Hepatitis C at EASL,Annual Meeting 4
Used following open gallbladder procedure to drain bile. Often attached to Bard bile bag.
Hubbed drains are made of translucent silicone and include a full-length X-ray opaque stripe.
Bard® Channel Drain
Used for percutaneous placement of laparoscopic surgical instruments. Check-Flo® valve provides a secure seal around the instruments to be introduced. Supplied sterile in peel-open packages. Inte
Medicine Products: